GCT randomizes first patient into Phase III Women’s health study in Bulgaria

First two patients were screened last week and one already has been randomized to participate in a global multicentre study which is managed by GCT in Central-Eastern European region.

This study is aimed at preterm delivery prevention and we are very excited to be a part of it, helping to prevent the consequences for both infants and mothers.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2018 Global Clinical Trials, LLC

All rights reserved.